Meropenem inhibits D,D‐carboxypeptidase activity in Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Summary: Carbapenems such as meropenem are being investigated for their potential therapeutic utility against highly drug‐resistant tuberculosis. These β‐lactams target the transpeptidases that introduce interpeptide cross‐links into bacterial peptidoglycan thereby controlling rigidity of the bacterial envelope. Treatment of M ycobacterium tuberculosis (Mtb) with the β‐lactamase inhibitor clavulanate together with meropenem resulted in rapid, polar, cell lysis releasing cytoplasmic contents. In Mtb it has been previously demonstrated that 3‐3 cross‐linkages [involving two diaminopimelate (DAP) molecules] predominate over 4‐3 cross‐linkages (involving one DAP and one D‐alanine) in stationary‐phase cells. We purified and analysed peptidoglycan from Mtb and found that 3‐3 cross‐linkages predominate throughout all growth phases and the ratio of 4‐3/3‐3 linkages does not vary significantly under any growth condition. Meropenem treatment was accompanied by a dramatic accumulation of unlinked pentapeptide stems with no change in the tetrapeptide pools, suggesting that meropenem inhibits both a D,D‐carboxypeptidase and an L,D‐transpeptidase. We purified a candidate D,D‐carboxypeptidase DacB2 and showed that meropenem indeed directly inhibits this enzyme by forming a stable adduct at the enzyme active site. These results suggest that the rapid lysis of meropenem‐treated cells is the result of synergistically inhibiting the transpeptidases that introduce 3,3‐cross‐links while simultaneously limiting the pool of available substrates available for cross‐linking.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141 · cited 1×
“Non-replicating persistent cultures were prepared as described by Wayne and Hayes (1996) in Dubos medium, which consisted of Dubos broth base supplemented with 10¥ Dubos ADC enrichment [albumin (50 g l-1)/dextrose (75 g l-1)/ NaCl (8.5 g l-1)].”
MethodInfluentialNonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807 · cited 2×
“In view of this surprising result, we also studied the structure of PG from Mtb under conditions of non-replicating persistence (Wayne and Sohaskey, 2001).”
ResultGupta, R., Lavollay, M., Mainardi, J.-L., Arthur, M., Bishai, W. R., & Lamichhane, G. (2010) · Nature Medicine · doi:10.1038/nm.2120 · Cited by 281
The N,O-Diacetylmuramidase of Chalaropsis Species
Hash, J. H., & Rothlauf, M. V. (1967) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99397-x · Cited by 104
Cited by
Advances in the development of new tuberculosis drugs and treatment regimens
Zumla, A., Nahid, P., & Cole, S. T. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4001 · Cited by 893
The mycobacterial cell envelope — a moving target
Dulberger, C. L., Rubin, E. J., & Boutte, C. C. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0273-7 · Cited by 365
The Normalcy of Dormancy: Common Themes in Microbial Quiescence
Rittershaus, E. S. C., Baek, S.-H., & Sassetti, C. M. (2013) · Cell Host & Microbe · doi:10.1016/j.chom.2013.05.012 · Cited by 340
How sisters grow apart: mycobacterial growth and division
Kieser, K. J., & Rubin, E. J. (2014) · Nature Reviews Microbiology · doi:10.1038/nrmicro3299 · Cited by 268
Mycobacterial cell wall biosynthesis: a multifaceted antibiotic target
ABRAHAMS, K. A., & BESRA, G. S. (2018) · Parasitology · doi:10.1017/s0031182016002377 · Cited by 227
Metadata
- Authors
- Kumar, P., Arora, K., Lloyd, J. R., Lee, I. Y., Nair, V., Fischer, E., Boshoff, H. I. M., & Barry, C. E.
- Venue
- Molecular Microbiology
- Publisher
- Wiley
- Published
- 2012-08-28
- Volume
- 86
- Issue
- 2
- Pages
- 367-381
- ISSN
- 0950-382X (ISSN-L)
- 1365-2958
- OpenAlex
- W2096880413
- Cited by
- 146
- References
- 4
- FWCI
- 7.08
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.